Suits over heartburn drugs like Nexium and the blood-thinner Eliquis each could be consolidated in federal court.
The U.S. Judicial Panel on Multidistrict Litigation is set to hear arguments Jan. 26 to decide what path the cases against manufacturers should follow.
Plaintiffs allege AstraZeneca’s Nexium and Prilosec, Takeda Pharmaceuticals USA Inc.'s Prevacid, and over-the-counter drugs sold by Pfizer Inc. and Procter & Gamble Co. can cause kidney disease (In re Proton Pump Inhibitor Prods. Liab. Litig., J.P.M.L., MDL No. 2757, hearing 1/26/17).
The drugs—classified as proton pump inhibitors—work by suppressing the secretion of stomach acid.
Plaintiffs want ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.